ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 897

Prevalence of Inflammatory and Chronic Changes Suggestive of Axial Spondyloarthritis in Magnetic Resonance Images of the Axial Skeleton in Individuals < 45 Years in the General Populationas Part of a Large Community Study (SHIP)

Xenofon Baraliakos1, Daniel Feldmann2, Anne Ott2, Carsten Oliver Schmidt3, Martin Albers3, Adrian Richter3 and Jürgen Braun1, 1Ruhr-University Bochum, Herne, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), inflammation and spine involvement, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S088 ACR Abstract: Spondyloarthritis Incl PsA–Clinical I: Axial SpA Epidemiology (892–897)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Magnetic resonance imaging (MRI) is crucial for classification and diagnosis of axial spondyloarthritis (axSpA). Characteristic MRI lesions of axSpA are bone marrow edema (BME) or structural fatty lesions (FL) of the sacroiliac joints (SIJ) and spine. However, the specificity of these lesions has been questioned, since patients with chronic back pain but no axSpA may also have a positive MRI, as shown in recent cohort studies. In this study we investigate the prevalence of BME and FL on MRI of the spine and the SIJ in the general population.

Methods:

Volunteers <45 years of the population based Study of Health in Pomerania (SHIP)1,2underwent MRI examinations of the spine (sagittal orientation, T1 and T2 MRI sequences) and the SIJ (coronal orientation, STIR sequences), independently of clinical symptoms. Two trained readers blinded for age and gender of the examined persons evaluated the prevalence of BME (SIJ and spine) and FL (spine) suggestive of axSpA using the ASAS definitions: a lesion in the SIJ was considered positive if located periarticularly and in the middle part of the joint and A lesion in the spine was considered positive if detected at the edge of the vertebral body). Clearly degenerative lesions involving the vertebral endplate or being accompanied by abnormalities of the intervertebral disc (protrusion or prolapse) were not counted.

Results:

A total of 802 complete MRI sets (spine and SIJ) of 394 male (49.1%) and 408 female volunteers (50.9%) was evaluated. The mean age of all patients was 37.5±6.2 years. BME in the SIJ suggestive of axSpA were found in 144 individuals (18%), with an equal distribution between males (n=74, 18.8%) and females (n=70, 17.2%). A similar pattern of BME was found in the spine, again with no differences between males and females. However, the location of the lesions was different: 9.5% had ≥1 lesion in the cervical, 18.6% in the thoracic and 7.4% in the lumbar spine. Overall, 88.6% male and 84.6% female volunteers were found to have ≥1 and 54.6% male and 46.1% female volunteers were found to have at ≥3 positive spinal lesions in any spinal region. In comparison, the prevalence of FL was higher (36.7% volunteers in the cervical, 72.4% in the thoracic and 52.7% in the lumbar spine). Overall, 86.5% volunteers were found to have ≥1 and 50.2% volunteers were found to have ≥3 positive spinal lesions in any spinal segment.

Logistic regression analysis showed that age was the only demographic characteristic that independently contributed to the occurrence of both BME (RR=1.22, 95%CI 1.03-1.46, p<0.025) or FL ((RR=1.12, 95%CI 1.07-1.19, p<0.001).

Conclusion:

In this large population-based study with healthy volunteers a relatively high prevalence of inflammatory and structural MRI lesions was found. Whether these lesions are to be explained by mechanical stress needs to be further studied. The high prevalence of BME and FL in the axial skeleton in the general population indicates a limited diagnostic value of these MRI findings. Thus, those should be interpreted with caution in relation to diagnosis, classification and assessment of disease activity.

(1) Bundesgesundheitsbl 2012, (2) Völzke H et al. Int J Epidemiol 2011


Disclosure: X. Baraliakos, None; D. Feldmann, None; A. Ott, None; C. O. Schmidt, None; M. Albers, None; A. Richter, None; J. Braun, None.

To cite this abstract in AMA style:

Baraliakos X, Feldmann D, Ott A, Schmidt CO, Albers M, Richter A, Braun J. Prevalence of Inflammatory and Chronic Changes Suggestive of Axial Spondyloarthritis in Magnetic Resonance Images of the Axial Skeleton in Individuals < 45 Years in the General Populationas Part of a Large Community Study (SHIP) [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-inflammatory-and-chronic-changes-suggestive-of-axial-spondyloarthritis-in-magnetic-resonance-images-of-the-axial-skeleton-in-individuals-45-years-in-the-general-populationas-part-of-a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-inflammatory-and-chronic-changes-suggestive-of-axial-spondyloarthritis-in-magnetic-resonance-images-of-the-axial-skeleton-in-individuals-45-years-in-the-general-populationas-part-of-a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology